What is Lifesci Capital’s Forecast for CLDX Q2 Earnings?
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) – Analysts at Lifesci Capital issued their Q2 2025 earnings estimates for Celldex Therapeutics in a report released on Friday, June 13th. Lifesci Capital analyst S. Slutsky anticipates that the biopharmaceutical company will earn ($0.85) per share for the quarter. The consensus estimate for Celldex Therapeutics’ current full-year […]
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) – Analysts at Lifesci Capital issued their Q2 2025 earnings estimates for Celldex Therapeutics in a report released on Friday, June 13th. Lifesci Capital analyst S. Slutsky anticipates that the biopharmaceutical company will earn ($0.85) per share for the quarter. The consensus estimate for Celldex Therapeutics’ current full-year […]
